MCK
February 7, 2024 - AI Summary
Undervalued by 43.8% based on the discounted cash flow analysis.
Market cap | $68.78 Billion |
---|---|
Enterprise Value | $72.68 Billion |
Dividend Yield | $2.3971 (0.46%) |
Earnings per Share | $22.11 |
Beta | -0.0 |
Outstanding Shares | 131,408,286 |
Avg 30 Day Volume | 549,033 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 22.94 |
---|---|
PEG | -50.52 |
Price to Sales | 0.23 |
Price to Book Ratio | -32.43 |
Enterprise Value to Revenue | 0.24 |
Enterprise Value to EBIT | 18.72 |
Enterprise Value to Net Income | 24 |
Total Debt to Enterprise | 0.08 |
Debt to Equity | -2.87 |
No data
No data
McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. McKesson partners with pharmaceutical manufacturers, p...